Speaker illustration

Doctor Yusuke Sato

University of Fukui, Fukui (Japan)

Effects of PCSK9 inhibitor on adverse limb outcomes in patients with critical limb ischemia

Event: ESC Congress 2020

Topic: Pharmacotherapy

Session: Peripheral Vascular and Cerebrovascular Disease ePosters

Thumbnail

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb